The U.S. Food and Drug Administration announced that Actavis Inc. has recalled 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches from wholesale and retail locations after one patch was found to have released it active ingredient faster than normal. Read more at http://www.fda.gov/Safety/Recalls/ucm230498.htm.
Some fentanyl transdermal patches recalled
*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
